Literature DB >> 3304217

Activation mechanisms to chemical toxicity.

D V Parke.   

Abstract

The pathobiology of chemical toxicity may involve "acute lethal injury" (necrosis), "autoxidative injury" (oxygen toxicity), "immunological injury" (neoantigen formation), and malignancy. Toxic chemicals may be activated by reduction, conjugation, radical formation, or oxidation. Oxidative activation may be effected by cytochromes P-450/P-448, flavoprotein monooxygenases, or hydroxyl radicals. The alternative pathways of oxidative metabolism of toxic chemicals, namely, detoxication and activation, are catalysed by the phenobarbital-induced cytochromes P-450 and by the 3-methylcholanthrene-induced cytochromes P-448 respectively. Oxidative metabolism by cytochromes P-450 is followed by conjugation and detoxication, whereas oxidative metabolism by cytochromes P-448 yields reactive intermediates which are not readily conjugated, and thus react with vital intracellular macromolecules, resulting in necrosis, redox cycling and oxygen radical formation, neoantigen production, and mutations. The molecular dimensions of specific substrates, inhibitors and inducers of the PB-cytochromes P-450 indicate that they are globular and are different from those of the cytochromes P-448 which are planar, suggesting that the active sites of the two families of enzymes are different. Oxidative metabolism of planar substrates of cytochromes P-448 results in conformationally-hindered oxygenations, which inhibits subsequent conjugations. Cytochrome P-448 activity may be quantified by the oxidative deethylation of 7-ethoxyresorufin which, unlike benzo(a)pyrene hydroxylation (AHH) is a specific reaction for this family of enzymes. Oxidative metabolism of chemicals varies inversely with the body weight of the animal species, so that chemical toxicity involving oxidative activation, redox cycling, and reactive oxygen is greater the smaller the animal species.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304217     DOI: 10.1007/BF00296939

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  48 in total

1.  The role of mitomycin antibiotics in the chemotherapy of solid tumors.

Authors:  A C Sartorelli
Journal:  Biochem Pharmacol       Date:  1986-01-01       Impact factor: 5.858

2.  Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters.

Authors:  D von der Ahe; S Janich; C Scheidereit; R Renkawitz; G Schütz; M Beato
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

3.  The role of cytochrome P-450 forms in 2-aminoanthracene and benz[alpha]pyrene mutagenesis.

Authors:  R L Norman; U Muller-Eberhard; E F Johnson
Journal:  Biochem Biophys Res Commun       Date:  1979-07-12       Impact factor: 3.575

4.  Determination of cytochrome P-448 activity in biological tissues.

Authors:  C E Phillipson; P M Godden; P Y Lum; C Ioannides; D V Parke
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

Review 5.  Oxygen toxicity.

Authors:  L Frank; D Massaro
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

6.  Characteristics of a microsomal cytochrome P-448-mediated reaction. Ethoxyresorufin O-de-ethylation.

Authors:  M D Burke; R A Prough; R T Mayer
Journal:  Drug Metab Dispos       Date:  1977 Jan-Feb       Impact factor: 3.922

7.  Effects of phenobarbital and 3-methylcholanthrene on the in vivo distribution, metabolism and covalent binding of 4-ipomeanol in the rat; implications for target organ toxicity.

Authors:  C N Statham; M R Boyd
Journal:  Biochem Pharmacol       Date:  1982-12-15       Impact factor: 5.858

8.  Ellipticines as potent inhibitors of microsomes-dependent chemical mutagenesis.

Authors:  P Lesca; P Lecointe; C Paoletti; D Mansuy
Journal:  Chem Biol Interact       Date:  1979-05       Impact factor: 5.192

9.  Inactivation of a diol-epoxide and a K-region epoxide with high efficiency by glutathione transferase X.

Authors:  H Glatt; T Friedberg; P L Grover; P Sims; F Oesch
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

10.  Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver.

Authors:  H Yoshizawa; R Uchimaru; T Kamataki; R Kato; Y Ueno
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

View more
  11 in total

Review 1.  Principles of pharmacotherapy: II. Pharmacokinetics.

Authors:  T J Pallasch
Journal:  Anesth Prog       Date:  1988 Jul-Aug

2.  Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.

Authors:  R J Riley; P Roberts; M D Coleman; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

3.  A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes.

Authors:  N R Kitteringham; C Lambert; J L Maggs; J Colbert; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

4.  Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

5.  Long term neurotoxicity of styrene. A quantitative study of glial fibrillary acidic protein (GFA) and S-100.

Authors:  L E Rosengren; K G Haglid
Journal:  Br J Ind Med       Date:  1989-05

6.  A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro.

Authors:  R J Riley; C Lambert; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

7.  An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.

Authors:  R J Riley; J L Maggs; C Lambert; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

8.  COMPACT and molecular structure in toxicity assessment: a prospective evaluation of 30 chemicals currently being tested for rodent carcinogenicity by the NCI/NTP.

Authors:  D F Lewis; C Ioannides; D V Parke
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

9.  A retrospective evaluation of COMPACT predictions of the outcome of NTP rodent carcinogenicity testing.

Authors:  D F Lewis; C Ioannides; D V Parke
Journal:  Environ Health Perspect       Date:  1995-02       Impact factor: 9.031

10.  DNA adduct formation in the human nasal mucosa as a biomarker of exposure to environmental mutagens and carcinogens.

Authors:  S Flato; K Hemminki; E Thunberg; A Georgellis
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.